Coloniality in Intellectual Property Rights Legitimations: A Critical Discourse Analysis of The Pharmaceutical Industry’s Legitimation of Intellectual Property Rights During the COVID-19 Pandemic
The COVID-19 pandemic sparked a global debate on intellectual property rights involving various actors including nation states, civil society, and business. In October 2020, South Africa and India proposed that certain intellectual property rights on COVID-19 health products should be temporarily waivered for the remainder of the pandemic invoking strong opposition from the pharmaceutical industry
